MNKD
MANNKIND CORPPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 26 ▲ MannKind reported strong fourth quarter and full year 2025 financial…
- May 6 ▼ MannKind reported Q1 2026 GAAP EPS of -$0.05, a 600% miss vs. consen…
- May 12 ▼ 2 insiders sell $65.7K at $3.29
- May 29 ▲ MannKind received FDA approval for Afrezza® in children and adolesce…
- May 29 ▲ MannKind announced FDA approval of Afrezza (inhaled insulin) for ped…
- Jul 17 ▼ 2 insiders sell $310.7K at $4.06
- Jul 29 ▲ MannKind announced positive topline safety and tolerability results…
- Aug 7 ▼ 1 insider sell $158.5K at $4.06
- Sep 9 Contract: MannKind and Rose Pharma Inc Enter Licensing and Collabora…
- Sep 10 ▼ 1 insider sell $127.9K at $3.81
- Sep 25 ▼ 1 insider sell $128.5K at $3.29
- Oct 19 Chardan Capital initiates
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders sold $791.3K.
- InstitutionsBEARISH
Q3 2026: 19 added (0 new), 33 trimmed or exited.
- AnalystsBULLISH
13 of 15 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest +2.9% to 26.22M shares. 10.3 days to cover, ≈8.2% of shares.
- TrendUPTREND
11% above its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 6.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| VOYA INVESTMENT MANAGEMENT LLC | DOUBLED | $2.9M |
| Jump Financial, LLC | DOUBLED | $1.9M |
| ALPS ADVISORS INC | ADD | $1.7M |
| BARCLAYS PLC | ADD | $1.3M |
| Rafferty Asset Management, LLC | ADD | $1.2M |
| Mariner, LLC | TRIM | $1.2M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $1.2M |
| VANGUARD ASSET MANAGEMENT, Ltd | ADD | $887.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
15 analystsPrice is below the lowest target. Median implies +102%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 6, 2026 | RBC Capital MAINTAIN | Sector Perform |
| Nov 6, 2026 | Cantor Fitzgerald MAINTAIN | Overweight |
| Oct 20, 2026 | Cantor Fitzgerald REITERATE | Overweight |
| Oct 19, 2026 | Chardan Capital INITIATE | Buy |
| Oct 7, 2026 | Truist Securities MAINTAIN | Buy |
| Sep 11, 2026 | Cantor Fitzgerald REITERATE | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Binder Steven B. Director Sep 25, 2026 | SELL | $128.5K |
Binder Steven B. Director Sep 10, 2026 | SELL | $127.9K |
Binder Steven B. Director Aug 7, 2026 | SELL | $158.5K |
Binder Steven B. Director Jul 17, 2026 | SELL | $213.1K |
Thomson David EVP Genl Counsel & Secretary Jul 17, 2026 | SELL | $97.6K |
Binder Steven B. Director Jul 15, 2026 | EXERCISE | 93,790 sh |
Binder Steven B. Director Jul 15, 2026 | TAX W/H | $64.2K |
Binder Steven B. Director Jul 15, 2026 | TAX W/H | $16.7K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.02 | -$0.02–-$0.02 | +0.0% | $128.6M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
12 filings · 5 press releases · 3 bullish · 2 bearish · 1 mixed · 6 neutral- NEUTRAL SC 13GNov 10, 2026
State Street Corp filed a Schedule 13G disclosing a 4.7% passive stake in MannKind Corp as of…
Monitor future 13G amendments for stake increases or decreases; State Street's passive position is consistent with index fund management and does not signal a strategic view on the stock.
- NEUTRAL 8-KNov 5, 2026
MannKind reported Q3 2026 total revenue of $101.9M (+24% YoY), driven by Furoscix ($22.4M, up from…
Furoscix ReadyFlow adoption trajectory and Q4 revenue commentary (management expects Furoscix Q4 revenue to exceed H1 2026 total) are the key near-term catalysts. Monitor the Q4 2026 earnings call…
- BEARISH PRESS-RELEASENov 5, 2026
MannKind reported Q3 2026 total revenue of $101.9M (+24% YoY), slightly below the $108.5M…
Monitor Q4 2026 for Furoscix revenue trajectory, as management expects Q4 Furoscix revenue to exceed the first half of 2026 combined. Watch for updates on the global Phase 2 INFLO-2 trial for…
- NEUTRAL INST-CLUSTERNov 2, 2026
Four institutional asset managers reduced their MNKD positions in Q3 2026, with one near-exit and…
The selling is limited to small asset managers and does not involve top holders BlackRock, Rubric Capital, or State Street. Monitor next 13F for any change in behavior from the largest holders, as…
All MNKD filing & press-release reports (17)
- SC 13G reportNov 10, 2026
- 8-K reportNov 5, 2026
- PRESS-RELEASE reportNov 5, 2026
- INST-CLUSTER reportNov 2, 2026
- PRESS-RELEASE reportJul 29, 2026
- 8-K reportJul 24, 2026
- CLUSTER reportJul 17, 2026
- PRESS-RELEASE reportJun 3, 2026
- 8-K reportJun 2, 2026
- PRESS-RELEASE reportMay 29, 2026
- PRESS-RELEASE reportMay 29, 2026
- 8-K reportMay 28, 2026
- PRESS-RELEASE reportMay 27, 2026
- CLUSTER reportMay 12, 2026
- PRESS-RELEASE reportMay 6, 2026
- DEFA14A reportApr 7, 2026
- 8-K reportFeb 26, 2026